816TiP Randomized phase III trial on niraparib - TSR-042 (dostarlimab) vs physician’s choice CHEmotherapy in recurrent ovarian, fallopian tube or primary peritoneal cancer patients not candidate for platinum retreatment: NItCHE trial (MITO 33)
| Autor: | Lorusso, D., Musacchio, L., Pignata, S., Braicu, E.I., Cibula, D., Colombo, N., Frenel, J-S., Zagouri, F., Carbone, V., Ghizzoni, V., Giolitto, S., Giudice, E., Landolfo, C., Perri, M.T., Ricci, C., Salutari, V., Scambia, G. |
|---|---|
| Zdroj: | In Annals of Oncology September 2021 32 Supplement 5:S768-S769 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|